serw-MX  [xml]  
 


    
 DeCS Categories

D02 Organic Chemicals .
D02.092 Amines .
D02.092.146 Aniline Compounds .
D02.092.146.325 p-Dimethylaminoazobenzene .
D02.092.782 Polyamines .
D02.092.782.258 Diamines .
D02.092.782.258.368 Ethylenediamines .
D02.092.782.258.368.250 Edetic Acid .
D02.092.782.258.368.257 Egtazic Acid .
D02.241 Carboxylic Acids .
D02.241.081 Acids, Acyclic .
D02.241.081.018 Acetates .
D02.241.081.018.253 Edetic Acid .
D02.241.081.018.269 Egtazic Acid .
D03 Heterocyclic Compounds .
D03.383 Heterocyclic Compounds, 1-Ring .
D03.383.725 Pyridines .
D03.383.725.192 Dabigatran .
D03.633 Heterocyclic Compounds, Fused-Ring .
D03.633.100 Heterocyclic Compounds, 2-Ring .
D03.633.100.103 Benzimidazoles .
D03.633.100.103.280 Dabigatran .
N03 Health Care Economics and Organizations .
N03.219 Economics .
N03.219.521 Financing, Organized .
N03.219.521.710 Insurance, Health, Reimbursement .
N03.219.521.710.305 Reimbursement Mechanisms .
N03.219.521.710.305.200 Prospective Payment System .
N03.219.521.710.305.200.080 Diagnosis-Related Groups .
 
 Terms
 Synonyms & Historicals
Documents
LILACS e MDL
 
p-Dimethylaminoazobenzene .
4-Dimethylaminoazobenzene .
Methyl Yellow .
p-Dimethylaminoazobenzene, (E)-Isomer .
p-Dimethylaminoazobenzene, (Z)-Isomer .
4 Dimethylaminoazobenzene .
p Dimethylaminoazobenzene .
Butter Yellow .
Dimethylaminoazobenzene .
DAB 18460 .
A reagent used mainly to induce experimental liver cancer. According to the Fourth Annual Report on Carcinogens (NTP 85-002, p. 89) published in 1985, this compound "may reasonably be anticipated to be a carcinogen." (Merck, 11th ed) .
1.00
31326
 
Edetic Acid .
Calcium Disodium Edetate .
Calcium Disodium Versenate .
Calcium Tetacine .
Chelaton 3 .
Chromium EDTA .
Copper EDTA .
Coprin .
Dicobalt EDTA .
Disodium Calcitetracemate .
Disodium EDTA .
Disodium Ethylene Dinitrilotetraacetate .
Distannous EDTA .
Edetate Disodium Calcium .
Edetic Acid, Calcium Salt .
Edetic Acid, Calcium, Sodium Salt .
Edetic Acid, Chromium Salt .
Edetic Acid, Dipotassium Salt .
Edetic Acid, Disodium Salt .
Edetic Acid, Disodium Salt, Dihydrate .
Edetic Acid, Disodium, Magnesium Salt .
Edetic Acid, Disodium, Monopotassium Salt .
Edetic Acid, Magnesium Salt .
Edetic Acid, Monopotassium Salt .
Edetic Acid, Monosodium Salt .
Edetic Acid, Potassium Salt .
Edetic Acid, Sodium Salt .
Ethylene Dinitrilotetraacetate .
Ethylenedinitrilotetraacetic Acid .
Gallium EDTA .
Magnesium Disodium EDTA .
N,N'-1,2-Ethanediylbis(N-(carboxymethyl)glycine) .
Potassium EDTA .
Stannous EDTA .
Versenate .
Versene .
Acid, Edetic .
Acid, Ethylenediaminetetraacetic .
Acid, Ethylenedinitrilotetraacetic .
Calcitetracemate, Disodium .
Dinitrilotetraacetate, Disodium Ethylene .
Dinitrilotetraacetate, Ethylene .
Disodium Versenate, Calcium .
EDTA, Chromium .
EDTA, Copper .
EDTA, Dicobalt .
EDTA, Disodium .
EDTA, Distannous .
EDTA, Gallium .
EDTA, Magnesium Disodium .
EDTA, Potassium .
EDTA, Stannous .
Edetate, Calcium Disodium .
Ethylene Dinitrilotetraacetate, Disodium .
Tetacine, Calcium .
Versenate, Calcium Disodium .
Edathamil .
Edetates .
Ethylenediaminetetraacetic Acid .
Tetracemate .
EDTA 18465 .
A chelating agent that sequesters a variety of polyvalent cations such as CALCIUM. It is used in pharmaceutical manufacturing and as a food additive. .
0.46
32323559
 
Egtazic Acid .
EGATA .
Egtazic Acid Disodium Salt .
Egtazic Acid Potassium Salt .
Egtazic Acid Sodium Salt .
Ethylene Glycol Bis(2-aminoethyl ether)tetraacetic Acid .
Ethylenebis(oxyethylenenitrile)tetraacetic Acid .
GEDTA .
Glycoletherdiamine-N,N,N',N'-tetraacetic Acid .
Magnesium-EGTA .
Tetrasodium EGTA .
Acid, Egtazic .
EGTA, Tetrasodium .
Magnesium EGTA .
Ethylene Glycol Tetraacetic Acid .
EGTA 18466 .
A chelating agent relatively more specific for calcium and less toxic than EDETIC ACID. .
0.45
199871
 
Diagnosis-Related Groups .
Case Mixes .
DRGs 18471 .
Diagnostic-Related Group .
Group, Diagnostic-Related .
Groups, Diagnostic-Related .
Diagnosis Related Groups .
Diagnosis-Related Group .
Diagnostic Related Group .
Diagnostic-Related Groups .
Group, Diagnosis-Related .
Group, Diagnostic Related .
Groups, Diagnosis-Related .
Groups, Diagnostic Related .
Case Mix .
DRG 18471 .
A system for classifying patient care by relating common characteristics such as diagnosis, treatment, and age to an expected consumption of hospital resources and length of stay. Its purpose is to provide a framework for specifying case mix and to reduce hospital costs and reimbursements and it forms the cornerstone of the prospective payment system. .
0.45
13810304
 
Dabigatran .
BIBR 1048 .
Dabigatran Etexilate .
Dabigatran Etexilate Mesylate .
N-((2-(((4-(aminoiminomethyl)phenyl)amino)methyl)-1-methyl-1H-benzimidazol-5-yl)carbonyl)-N-2-pyridinyl-beta-alanine .
Pradaxa .
Etexilate Mesylate, Dabigatran .
Etexilate, Dabigatran .
Mesylate, Dabigatran Etexilate .
A THROMBIN inhibitor which acts by binding and blocking thrombogenic activity and the prevention of thrombus formation. It is used to reduce the risk of stroke and systemic EMBOLISM in patients with nonvalvular atrial fibrillation. .
0.44
292203